-
1
-
-
0031014282
-
Transforming growth factor beta type II receptor gene mutations in adenomas from hereditary nonpolyposis colorectal cancer
-
Akiyama, Y., Iwanaga, R., Saitoh, K., Shiba, K., Ushio, K., Ikeda, E., Iwama, T., Nomizu, T. and Yuasa, Y. (1997) Transforming growth factor beta type II receptor gene mutations in adenomas from hereditary nonpolyposis colorectal cancer. Gastroenterology 112, 33-39.
-
(1997)
Gastroenterology
, vol.112
, pp. 33-39
-
-
Akiyama, Y.1
Iwanaga, R.2
Saitoh, K.3
Shiba, K.4
Ushio, K.5
Ikeda, E.6
Iwama, T.7
Nomizu, T.8
Yuasa, Y.9
-
2
-
-
0027137485
-
Anti-transforming growth factor (TGF)-beta antibodies inhibit breast cancer cell tumorigenicity and increase mouse spleen natural killer cell activity. Implications for a possible role of tumor cell/host TGF-beta interactions in human breast cancer progression
-
Arteaga, C., Hurd, S., Winnier, A., Johnson, M., Fendly, B. and Forbes, J. (1993) Anti-transforming growth factor (TGF)-beta antibodies inhibit breast cancer cell tumorigenicity and increase mouse spleen natural killer cell activity. Implications for a possible role of tumor cell/host TGF-beta interactions in human breast cancer progression. J. Clin. Invest. 92, 2569-2576.
-
(1993)
J. Clin. Invest
, vol.92
, pp. 2569-2576
-
-
Arteaga, C.1
Hurd, S.2
Winnier, A.3
Johnson, M.4
Fendly, B.5
Forbes, J.6
-
3
-
-
33746145265
-
Inhibition of pulmonary and skeletal metastasis by a transforming growth factor-β type I receptor kinase inhibitor
-
Bandyopadhyay, A., Agyin, J. K., Wang, L., Tang, Y., Lei, X., Story, B. M., Cornell, J. E., Pollock, B. H., Mundy, G. R. and Sun, L.-Z. (2006) Inhibition of pulmonary and skeletal metastasis by a transforming growth factor-β type I receptor kinase inhibitor. Cancer Res. 66, 6714-6721.
-
(2006)
Cancer Res
, vol.66
, pp. 6714-6721
-
-
Bandyopadhyay, A.1
Agyin, J.K.2
Wang, L.3
Tang, Y.4
Lei, X.5
Story, B.M.6
Cornell, J.E.7
Pollock, B.H.8
Mundy, G.R.9
Sun, L.-Z.10
-
4
-
-
34248185926
-
Inhibition of TGF-β with neutralizing antibodies prevents radiation-induced acceleration of metastatic cancer progression
-
Biswas, S., Guix, M., Rinehart, C., Dugger, T. C., Chytil, A., Moses, H. L., Freeman, M. L. and Arteaga, C. L. (2007) Inhibition of TGF-β with neutralizing antibodies prevents radiation-induced acceleration of metastatic cancer progression. J. Clin. Invest. 117, 1305-1313.
-
(2007)
J. Clin. Invest
, vol.117
, pp. 1305-1313
-
-
Biswas, S.1
Guix, M.2
Rinehart, C.3
Dugger, T.C.4
Chytil, A.5
Moses, H.L.6
Freeman, M.L.7
Arteaga, C.L.8
-
5
-
-
37149042061
-
Semi-mechanistic modelling of the tumour growth inhibitory effects of LY2157299, a new type I receptor TGF-β kinase antagonist, in mice
-
Bueno, L., de Alwis, D. P., Pitou, C., Yingling, J., Lahn, M., Glatt, S. and Trocóniz, I. F. (2008) Semi-mechanistic modelling of the tumour growth inhibitory effects of LY2157299, a new type I receptor TGF-β kinase antagonist, in mice. Eur. J. Cancer 44, 142-150.
-
(2008)
Eur. J. Cancer
, vol.44
, pp. 142-150
-
-
Bueno, L.1
de Alwis, D.P.2
Pitou, C.3
Yingling, J.4
Lahn, M.5
Glatt, S.6
Trocóniz, I.F.7
-
6
-
-
84862488155
-
Inhibition of TGFbeta signaling and its implications in anticancer treatments
-
Calone, I. and Souchelnytskyi, S. (2012) Inhibition of TGFbeta signaling and its implications in anticancer treatments. Exp. Oncol. 34, 9-16.
-
(2012)
Exp. Oncol
, vol.34
, pp. 9-16
-
-
Calone, I.1
Souchelnytskyi, S.2
-
7
-
-
0029015704
-
Reduced surface expression of transforming growth factor beta receptor type II in mitogen-activated T cells from Sezary patients
-
Capocasale, R. J., Lamb, R. J., Vonderheid, E. C., Fox, F. E., Rook, A. H., Nowell, P. C. and Moore, J. S. (1995) Reduced surface expression of transforming growth factor beta receptor type II in mitogen-activated T cells from Sezary patients. Proc. Natl. Acad. Sci. U.S.A. 92, 5501-5505.
-
(1995)
Proc. Natl. Acad. Sci. U.S.A
, vol.92
, pp. 5501-5505
-
-
Capocasale, R.J.1
Lamb, R.J.2
Vonderheid, E.C.3
Fox, F.E.4
Rook, A.H.5
Nowell, P.C.6
Moore, J.S.7
-
8
-
-
0035452460
-
Novel inactivating mutations of transforming growth factor-β type I receptor gene in head-and-neck cancer me-tastases
-
Chen, T., Yan, W., Wells, R. G., Rimm, D. L., McNiff, J., Leffell, D. and Reiss, M. (2001) Novel inactivating mutations of transforming growth factor-β type I receptor gene in head-and-neck cancer me-tastases. Int. J. Cancer 93, 653-661.
-
(2001)
Int. J. Cancer
, vol.93
, pp. 653-661
-
-
Chen, T.1
Yan, W.2
Wells, R.G.3
Rimm, D.L.4
McNiff, J.5
Leffell, D.6
Reiss, M.7
-
9
-
-
84866029510
-
Complexities of TGF-β targeted cancer therapy
-
Connolly, E. C., Freimuth, J. and Akhurst, R. J. (2012) Complexities of TGF-β targeted cancer therapy. Int. J. Biol. Sci. 8, 964-978.
-
(2012)
Int. J. Biol. Sci
, vol.8
, pp. 964-978
-
-
Connolly, E.C.1
Freimuth, J.2
Akhurst, R.J.3
-
10
-
-
79952771133
-
Outgrowth of drug-resistant carcinomas expressing markers of tumor aggression after long-term TβRI/II kinase inhibition with LY2109761
-
Connolly, E. C., Saunier, E. F., Quigley, D., Luu, M. T., De Sapio, A., Hann, B., Yingling, J. M. and Akhurst, R. J. (2011) Outgrowth of drug-resistant carcinomas expressing markers of tumor aggression after long-term TβRI/II kinase inhibition with LY2109761. Cancer Res. 71, 2339-2349.
-
(2011)
Cancer Res
, vol.71
, pp. 2339-2349
-
-
Connolly, E.C.1
Saunier, E.F.2
Quigley, D.3
Luu, M.T.4
de Sapio, A.5
Hann, B.6
Yingling, J.M.7
Akhurst, R.J.8
-
11
-
-
1342265719
-
SB-505124 is a selective inhibitor of transforming growth factor-β type I receptors ALK4, ALK5, and ALK7
-
DaCosta Byfield, S. D., Major, C., Laping, N. J. and Roberts, A. B. (2004) SB-505124 is a selective inhibitor of transforming growth factor-β type I receptors ALK4, ALK5, and ALK7. Mol. Pharmacol. 65, 744-752.
-
(2004)
Mol. Pharmacol
, vol.65
, pp. 744-752
-
-
DaCosta Byfield, S.D.1
Major, C.2
Laping, N.J.3
Roberts, A.B.4
-
12
-
-
72049095695
-
Transforming growth factor-β (TGF-β) signaling inhibitors cancer therapy in: Transforming Growth Factor-β in Cancer Therapy
-
Human Press
-
Datta, P. K. and Mann, J. R. (2008) Transforming growth factor-β (TGF-β) signaling inhibitors cancer therapy in: Transforming Growth Factor-β in Cancer Therapy. In Cancer Treatment and therapy, Volume II, pp.573-587, Human Press.
-
(2008)
Cancer Treatment and Therapy
, vol.2
, pp. 573-587
-
-
Datta, P.K.1
Mann, J.R.2
-
13
-
-
34548329486
-
Differentiation plasticity regulated by TGF-β family proteins in development and disease
-
Derynck, R. and Akhurst, R. J. (2007) Differentiation plasticity regulated by TGF-β family proteins in development and disease. Nat. Cell Biol. 9, 1000-1004.
-
(2007)
Nat. Cell Biol
, vol.9
, pp. 1000-1004
-
-
Derynck, R.1
Akhurst, R.J.2
-
14
-
-
0034785348
-
TGF-β signaling in tumor suppression and cancer progression
-
Derynck, R., Akhurst, R. J. and Balmain, A. (2001) TGF-β signaling in tumor suppression and cancer progression. Nat. Genet. 29, 117-129.
-
(2001)
Nat. Genet
, vol.29
, pp. 117-129
-
-
Derynck, R.1
Akhurst, R.J.2
Balmain, A.3
-
15
-
-
0142104985
-
Smad-dependent and Smad-in-dependent pathways in TGF-β family signalling
-
Derynck, R. and Zhang, Y. E. (2003) Smad-dependent and Smad-in-dependent pathways in TGF-β family signalling. Nature 425, 577-584.
-
(2003)
Nature
, vol.425
, pp. 577-584
-
-
Derynck, R.1
Zhang, Y.E.2
-
16
-
-
33745082823
-
Role of transforming growth factor-β in hematologic malignancies
-
Dong, M. and Blobe, G. C. (2006) Role of transforming growth factor-β in hematologic malignancies. Blood 107, 4589-4596.
-
(2006)
Blood
, vol.107
, pp. 4589-4596
-
-
Dong, M.1
Blobe, G.C.2
-
17
-
-
33751328068
-
Ki26894, a novel transforming growth factor-β type I receptor ki-nase inhibitor, inhibits in vitro invasion and in vivo bone metastasis of a human breast cancer cell line
-
Ehata, S., Hanyu, A., Fujime, M., Katsuno, Y., Fukunaga, E., Goto, K., Ishikawa, Y., Nomura, K., Yokoo, H. and Shimizu, T. (2007) Ki26894, a novel transforming growth factor-β type I receptor ki-nase inhibitor, inhibits in vitro invasion and in vivo bone metastasis of a human breast cancer cell line. Cancer Sci. 98, 127-133.
-
(2007)
Cancer Sci
, vol.98
, pp. 127-133
-
-
Ehata, S.1
Hanyu, A.2
Fujime, M.3
Katsuno, Y.4
Fukunaga, E.5
Goto, K.6
Ishikawa, Y.7
Nomura, K.8
Yokoo, H.9
Shimizu, T.10
-
18
-
-
16044369574
-
MADR2 maps to 18q21 and encodes a TGFβ-regulated MAD-related protein that is functionally mutated in colorectal carcinoma
-
Eppert, K., Scherer, S. W., Ozcelik, H., Pirone, R., Hoodless, P., Kim, H., Tsui, L.-C., Bapat, B., Gallinger, S. and Andrulis, I. L. (1996). MADR2 maps to 18q21 and encodes a TGFβ-regulated MAD-related protein that is functionally mutated in colorectal carcinoma. Cell 86, 543-552.
-
(1996)
Cell
, vol.86
, pp. 543-552
-
-
Eppert, K.1
Scherer, S.W.2
Ozcelik, H.3
Pirone, R.4
Hoodless, P.5
Kim, H.6
Tsui, L.-C.7
Bapat, B.8
Gallinger, S.9
Andrulis, I.L.10
-
19
-
-
0037141103
-
Disruption of transforming growth factor β signaling by a novel ligand-dependent mechanism
-
Fernandez, T., Amoroso, S., Sharpe, S., Jones, G. M., Bliskovski, V., Kovalchuk, A., Wakefield, L. M., Kim, S.-J., Potter, M. and Letterio, J. J. (2002) Disruption of transforming growth factor β signaling by a novel ligand-dependent mechanism. J. Exp. Med. 195, 1247-1255.
-
(2002)
J. Exp. Med
, vol.195
, pp. 1247-1255
-
-
Fernandez, T.1
Amoroso, S.2
Sharpe, S.3
Jones, G.M.4
Bliskovski, V.5
Kovalchuk, A.6
Wakefield, L.M.7
Kim, S.-J.8
Potter, M.9
Letterio, J.J.10
-
20
-
-
77954951446
-
The polarization of immune cells in the tumour environment by TGFβ
-
Flavell, R. A., Sanjabi, S., Wrzesinski, S. H. and Licona-Limón, P. (2010). The polarization of immune cells in the tumour environment by TGFβ. Nat. Rev. Immunol. 10, 554-567.
-
(2010)
Nat. Rev. Immunol
, vol.10
, pp. 554-567
-
-
Flavell, R.A.1
Sanjabi, S.2
Wrzesinski, S.H.3
Licona-Limón, P.4
-
21
-
-
77952609184
-
Targeting the transforming growth factor-β pathway inhibits human basal-like breast cancer metastasis
-
Ganapathy, V., Ge, R., Grazioli, A., Xie, W., Banach-Petrosky, W., Kang, Y., Lonning, S., McPherson, J., Yingling, J. M. and Biswas, S. (2010) Targeting the transforming growth factor-β pathway inhibits human basal-like breast cancer metastasis. Mol. Cancer 9, 122.
-
(2010)
Mol. Cancer
, vol.9
, pp. 122
-
-
Ganapathy, V.1
Ge, R.2
Grazioli, A.3
Xie, W.4
Banach-Petrosky, W.5
Kang, Y.6
Lonning, S.7
McPherson, J.8
Yingling, J.M.9
Biswas, S.10
-
22
-
-
0032404111
-
Genetic alterations of the transforming growth factor β receptor genes in pancreatic and biliary adenocar-cinomas
-
Goggins, M., Shekher, M., Turnacioglu, K., Yeo, C. J., Hruban, R. H. and Kern, S. E. (1998) Genetic alterations of the transforming growth factor β receptor genes in pancreatic and biliary adenocar-cinomas. Cancer Res. 58, 5329-5332.
-
(1998)
Cancer Res
, vol.58
, pp. 5329-5332
-
-
Goggins, M.1
Shekher, M.2
Turnacioglu, K.3
Yeo, C.J.4
Hruban, R.H.5
Kern, S.E.6
-
23
-
-
84872320891
-
A Phase I study of tasisulam sodium (LY573636 sodium), a novel anticancer compound, administered as a 24-h continuous infusion in patients with advanced solid tumors
-
Gordon, M. S., Ilaria, R. Jr., de Alwis, D. P., Mendelson, D. S., McKane, S., Wagner, M. M., Look, K. Y. and LoRusso, P. M. (2013) A Phase I study of tasisulam sodium (LY573636 sodium), a novel anticancer compound, administered as a 24-h continuous infusion in patients with advanced solid tumors. Cancer Chemother. Pharmacol. 71, 21-27.
-
(2013)
Cancer Chemother. Pharmacol
, vol.71
, pp. 21-27
-
-
Gordon, M.S.1
Ilaria Jr., R.2
de Alwis, D.P.3
Mendelson, D.S.4
McKane, S.5
Wagner, M.M.6
Look, K.Y.7
Lorusso, P.M.8
-
24
-
-
0033555627
-
Mutational inactivation of transforming growth factor β receptor type II in microsatellite stable colon cancers
-
Grady, W. M., Myeroff, L. L., Swinler, S. E., Rajput, A., Thiagalingam, S., Lutterbaugh, J. D., Neumann, A., Brattain, M. G., Chang, J. and Kim, S.-J. (1999) Mutational inactivation of transforming growth factor β receptor type II in microsatellite stable colon cancers. Cancer Res. 59, 320-324.
-
(1999)
Cancer Res
, vol.59
, pp. 320-324
-
-
Grady, W.M.1
Myeroff, L.L.2
Swinler, S.E.3
Rajput, A.4
Thiagalingam, S.5
Lutterbaugh, J.D.6
Neumann, A.7
Brattain, M.G.8
Chang, J.9
Kim, S.-J.10
-
25
-
-
0032527902
-
Mutation of the type II transforming growth factor-β receptor is coincident with the transformation of human colon adenomas to malignant carcinomas
-
Grady, W. M., Rajput, A., Myeroff, L., Liu, D. F., Kwon, K., Willis, J. and Markowitz, S. (1998) Mutation of the type II transforming growth factor-β receptor is coincident with the transformation of human colon adenomas to malignant carcinomas. Cancer Res. 58, 3101-3104.
-
(1998)
Cancer Res
, vol.58
, pp. 3101-3104
-
-
Grady, W.M.1
Rajput, A.2
Myeroff, L.3
Liu, D.F.4
Kwon, K.5
Willis, J.6
Markowitz, S.7
-
26
-
-
0035315836
-
Synthesis and degradation of basement membranes and extracellular matrix and their regulation by TGF-β in invasive carcinomas (Review)
-
Hagedorn, H. G., Bachmeier, B. E. and Nerlich, A. G. (2001) Synthesis and degradation of basement membranes and extracellular matrix and their regulation by TGF-β in invasive carcinomas (Review). Int. J. Oncol. 18, 669-681.
-
(2001)
Int. J. Oncol
, vol.18
, pp. 669-681
-
-
Hagedorn, H.G.1
Bachmeier, B.E.2
Nerlich, A.G.3
-
27
-
-
34547187636
-
Inhibition of TGF-β 2 with ap 12009 in recurrent malignant gliomas: From preclinical to phase I/II studies
-
Hau, P., Jachimczak, P., Schlingensiepen, R., Schulmeyer, F., Jauch, T., Steinbrecher, A., Brawanski, A., Proescholdt, M., Schlaier, J. and Buchroithner, J. (2007) Inhibition of TGF-β 2 with ap 12009 in recurrent malignant gliomas: from preclinical to phase I/II studies. Oligonucleotides 17, 201-212.
-
(2007)
Oligonucleotides
, vol.17
, pp. 201-212
-
-
Hau, P.1
Jachimczak, P.2
Schlingensiepen, R.3
Schulmeyer, F.4
Jauch, T.5
Steinbrecher, A.6
Brawanski, A.7
Proescholdt, M.8
Schlaier, J.9
Buchroithner, J.10
-
28
-
-
0031438047
-
TGF-β signaling from cell membrane to nucleus through SMAD proteins
-
Heldin, C.-H., Miyazono, K. and Ten Dijke, P. (1997) TGF-β signaling from cell membrane to nucleus through SMAD proteins. Nature 390, 465-471.
-
(1997)
Nature
, vol.390
, pp. 465-471
-
-
Heldin, C.-H.1
Miyazono, K.2
Ten Dijke, P.3
-
29
-
-
4444341835
-
SB-431542, a small molecule transforming growth factor-β-receptor antagonist, inhibits human glioma cell line proliferation and motility
-
Hjelmeland, M. D., Hjelmeland, A. B., Sathornsumetee, S., Reese, E. D., Herbstreith, M. H., Laping, N. J., Friedman, H. S., Bigner, D. D., Wang, X.-F. and Rich, J. N. (2004) SB-431542, a small molecule transforming growth factor-β-receptor antagonist, inhibits human glioma cell line proliferation and motility. Mol. Cancer Ther. 3, 737-745.
-
(2004)
Mol. Cancer Ther
, vol.3
, pp. 737-745
-
-
Hjelmeland, M.D.1
Hjelmeland, A.B.2
Sathornsumetee, S.3
Reese, E.D.4
Herbstreith, M.H.5
Laping, N.J.6
Friedman, H.S.7
Bigner, D.D.8
Wang, X.-F.9
Rich, J.N.10
-
30
-
-
25444479744
-
Breast cancer bone metastasis mediated by the Smad tumor suppressor pathway
-
Kang, Y., He, W., Tulley, S., Gupta, G. P., Serganova, I., Chen, C.-R., Manova-Todorova, K., Blasberg, R., Gerald, W. L. and Massagué, J. (2005) Breast cancer bone metastasis mediated by the Smad tumor suppressor pathway. Proc. Natl. Acad. Sci. U.S.A. 102, 13909-13914.
-
(2005)
Proc. Natl. Acad. Sci. U.S.A
, vol.102
, pp. 13909-13914
-
-
Kang, Y.1
He, W.2
Tulley, S.3
Gupta, G.P.4
Serganova, I.5
Chen, C.-R.6
Manova-Todorova, K.7
Blasberg, R.8
Gerald, W.L.9
Massagué, J.10
-
31
-
-
0038488950
-
A multigenic program mediating breast cancer metastasis to bone
-
Kang, Y., Siegel, P. M., Shu, W., Drobnjak, M., Kakonen, S. M., Cor-dén-Cardo, C., Guise, T. A. and Massagué, J. (2003) A multigenic program mediating breast cancer metastasis to bone. Cancer Cell 3, 537-549.
-
(2003)
Cancer Cell
, vol.3
, pp. 537-549
-
-
Kang, Y.1
Siegel, P.M.2
Shu, W.3
Drobnjak, M.4
Kakonen, S.M.5
Cor-dén-Cardo, C.6
Guise, T.A.7
Massagué, J.8
-
32
-
-
84885079730
-
2-pyridyl substituted imidazoles as therapeutic ALK5 and/or ALK4 inhibitors
-
PCT/KR2011/004631
-
Kim, D.-K., Sheen, Y. Y., Jin, C., Park, C.-Y., Domalapally, S., Kota, S. R., Maddeboina, K. and Bala, S. V. (2011) 2-pyridyl substituted imidazoles as therapeutic ALK5 and/or ALK4 inhibitors. Google Patents. PCT/KR2011/004631.
-
(2011)
Google Patents
-
-
Kim, D.-K.1
Sheen, Y.Y.2
Jin, C.3
Park, C.-Y.4
Domalapally, S.5
Kota, S.R.6
Maddeboina, K.7
Bala, S.V.8
-
33
-
-
0028180315
-
The TGF-beta superfamily: New members, new receptors, and new genetic tests of function in different organisms
-
Kingsley, D. M. (1994) The TGF-beta superfamily: new members, new receptors, and new genetic tests of function in different organisms. Genes Dev. 8, 133-146.
-
(1994)
Genes Dev
, vol.8
, pp. 133-146
-
-
Kingsley, D.M.1
-
34
-
-
35848970582
-
Molecular biology of bone metastasis
-
Kingsley, L. A., Fournier, P. G., Chirgwin, J. M. and Guise, T. A. (2007) Molecular biology of bone metastasis. Mol. Cancer Ther. 6, 2609-2617.
-
(2007)
Mol. Cancer Ther
, vol.6
, pp. 2609-2617
-
-
Kingsley, L.A.1
Fournier, P.G.2
Chirgwin, J.M.3
Guise, T.A.4
-
35
-
-
68349160814
-
Imaging transforming growth factor-β signaling dynamics and therapeutic response in breast cancer bone metastasis
-
Korpal, M., Yan, J., Lu, X., Xu, S., Lerit, D. A. and Kang, Y. (2009) Imaging transforming growth factor-β signaling dynamics and therapeutic response in breast cancer bone metastasis. Nat. Med. 15, 960-966.
-
(2009)
Nat. Med
, vol.15
, pp. 960-966
-
-
Korpal, M.1
Yan, J.2
Lu, X.3
Xu, S.4
Lerit, D.A.5
Kang, Y.6
-
36
-
-
82355190200
-
TGF-beta signaling in colon carcinogenesis
-
Lampropoulos, P., Zizi-Sermpetzoglou, A., Rizos, S., Kostakis, A., Ni-kiteas, N. and Papavassiliou, A. G. (2012) TGF-beta signaling in colon carcinogenesis. Cancer Lett. 314, 1-7.
-
(2012)
Cancer Lett
, vol.314
, pp. 1-7
-
-
Lampropoulos, P.1
Zizi-Sermpetzoglou, A.2
Rizos, S.3
Kostakis, A.4
Ni-Kiteas, N.5
Papavassiliou, A.G.6
-
37
-
-
34247864012
-
Three-dimensional culture models of normal and malignant breast epithelial cells
-
Lee, G. Y., Kenny, P. A., Lee, E. H. and Bissell, M. J. (2007) Three-dimensional culture models of normal and malignant breast epithelial cells. Nat. Methods 4, 359-365.
-
(2007)
Nat. Methods
, vol.4
, pp. 359-365
-
-
Lee, G.Y.1
Kenny, P.A.2
Lee, E.H.3
Bissell, M.J.4
-
38
-
-
30944444113
-
Alterations in components of the TGF-β superfamily signaling pathways in human cancer
-
Levy, L. and Hill, C. S. (2006) Alterations in components of the TGF-β superfamily signaling pathways in human cancer. Cytokine Growth Factor Rev. 17, 41-58.
-
(2006)
Cytokine Growth Factor Rev
, vol.17
, pp. 41-58
-
-
Levy, L.1
Hill, C.S.2
-
39
-
-
77956262480
-
Molecular characterization of TGFβ-induced epithelial-mesenchymal transition in normal finite lifespan human mammary epithelial cells
-
Lindley, L. E. and Briegel, K. J. (2010) Molecular characterization of TGFβ-induced epithelial-mesenchymal transition in normal finite lifespan human mammary epithelial cells. Biochem. Biophys. Res. Commun. 399, 659-664.
-
(2010)
Biochem. Biophys. Res. Commun
, vol.399
, pp. 659-664
-
-
Lindley, L.E.1
Briegel, K.J.2
-
40
-
-
0042066370
-
Loss of expression, and mutations of Smad 2 and Smad 4 in human cervical cancer
-
Maliekal, T. T., Antony, M.-L., Nair, A., Paulmurugan, R. and Karuna-garan, D. (2003) Loss of expression, and mutations of Smad 2 and Smad 4 in human cervical cancer. Oncogene 22, 4889-4897.
-
(2003)
Oncogene
, vol.22
, pp. 4889-4897
-
-
Maliekal, T.T.1
Antony, M.-L.2
Nair, A.3
Paulmurugan, R.4
Karuna-Garan, D.5
-
41
-
-
43049165453
-
The epithelial-mesenchymal transition generates cells with properties of stem cells
-
Mani, S. A., Guo, W., Liao, M.-J., Eaton, E. N., Ayyanan, A., Zhou, A. Y., Brooks, M., Reinhard, F., Zhang, C. C. and Shipitsin, M. (2008) The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 133, 704-715.
-
(2008)
Cell
, vol.133
, pp. 704-715
-
-
Mani, S.A.1
Guo, W.2
Liao, M.-J.3
Eaton, E.N.4
Ayyanan, A.5
Zhou, A.Y.6
Brooks, M.7
Reinhard, F.8
Zhang, C.C.9
Shipitsin, M.10
-
42
-
-
0029066689
-
Inactivation of the type II TGF-beta receptor in colon cancer cells with microsatellite instability
-
Markowitz, S., Wang, J., Myeroff, L., Parsons, R., Sun, L., Lutter-baugh, J., Fan, R. S., Zborowska, E., Kinzler, K. W. and Vogelstein, B. (1995) Inactivation of the type II TGF-beta receptor in colon cancer cells with microsatellite instability. Science 268, 1336-1338.
-
(1995)
Science
, vol.268
, pp. 1336-1338
-
-
Markowitz, S.1
Wang, J.2
Myeroff, L.3
Parsons, R.4
Sun, L.5
Lutter-Baugh, J.6
Fan, R.S.7
Zborowska, E.8
Kinzler, K.W.9
Vogelstein, B.10
-
43
-
-
0034574298
-
How cells read TGF-β signals
-
Massagué, J. (2000) How cells read TGF-β signals. Nat. Rev. Mol. Cell Biol. 1, 169-178.
-
(2000)
Nat. Rev. Mol. Cell Biol
, vol.1
, pp. 169-178
-
-
Massagué, J.1
-
44
-
-
47549090432
-
TGFβ in cancer
-
Massagué, J. (2008) TGFβ in cancer. Cell 134, 215-230.
-
(2008)
Cell
, vol.134
, pp. 215-230
-
-
Massagué, J.1
-
45
-
-
33646562542
-
The logic of TGFβ signaling
-
Massagué, J. and Gomis, R. R. (2006) The logic of TGFβ signaling. FEBS Lett. 580, 2811-2820.
-
(2006)
FEBS Lett
, vol.580
, pp. 2811-2820
-
-
Massagué, J.1
Gomis, R.R.2
-
46
-
-
10744225133
-
SB-431542 and Gleevec inhibit transforming growth factor-β-induced proliferation of human osteosarcoma cells
-
Matsuyama, S., Iwadate, M., Kondo, M., Saitoh, M., Hanyu, A., Shi-mizu, K., Aburatani, H., Mishima, H. K., Imamura, T. and Miyazono, K. (2003) SB-431542 and Gleevec inhibit transforming growth factor-β-induced proliferation of human osteosarcoma cells. Cancer Res. 63, 7791-7798.
-
(2003)
Cancer Res
, vol.63
, pp. 7791-7798
-
-
Matsuyama, S.1
Iwadate, M.2
Kondo, M.3
Saitoh, M.4
Hanyu, A.5
Shi-Mizu, K.6
Aburatani, H.7
Mishima, H.K.8
Imamura, T.9
Miyazono, K.10
-
47
-
-
42249099019
-
LY2109761, a novel transforming growth factor β receptor type I and type II dual inhibitor, as a therapeutic approach to suppressing pancreatic cancer metastasis
-
Melisi, D., Ishiyama, S., Sclabas, G. M., Fleming, J. B., Xia, Q., Tor-tora, G., Abbruzzese, J. L. and Chiao, P. J. (2008) LY2109761, a novel transforming growth factor β receptor type I and type II dual inhibitor, as a therapeutic approach to suppressing pancreatic cancer metastasis. Mol. Cancer Ther. 7, 829-840.
-
(2008)
Mol. Cancer Ther
, vol.7
, pp. 829-840
-
-
Melisi, D.1
Ishiyama, S.2
Sclabas, G.M.3
Fleming, J.B.4
Xia, Q.5
Tor-Tora, G.6
Abbruzzese, J.L.7
Chiao, P.J.8
-
48
-
-
78649982907
-
The dynamic roles of TGF-β in cancer
-
Meulmeester, E. and Ten Dijke, P. (2011). The dynamic roles of TGF-β in cancer. J. Pathol. 223, 205-218.
-
(2011)
J. Pathol
, vol.223
, pp. 205-218
-
-
Meulmeester, E.1
Ten Dijke, P.2
-
49
-
-
70349213381
-
The Six1 homeoprotein induces human mammary carcinoma cells to undergo epithelial-mesenchymal transition and metastasis in mice through increasing TGF-β signaling
-
Micalizzi, D. S., Christensen, K. L., Jedlicka, P., Coletta, R. D., Barón, A. E., Harrell, J. C., Horwitz, K. B., Billheimer, D., Heichman, K. A. and Welm, A. L. (2009) The Six1 homeoprotein induces human mammary carcinoma cells to undergo epithelial-mesenchymal transition and metastasis in mice through increasing TGF-β signaling. J. Clin.Invest. 119, 2678-2690.
-
(2009)
J. Clin.Invest
, vol.119
, pp. 2678-2690
-
-
Micalizzi, D.S.1
Christensen, K.L.2
Jedlicka, P.3
Coletta, R.D.4
Barón, A.E.5
Harrell, J.C.6
Horwitz, K.B.7
Billheimer, D.8
Heichman, K.A.9
Welm, A.L.10
-
50
-
-
78650359160
-
Homeoprotein Six1 increases TGF-β Type I receptor and converts TGF-β signaling from suppressive to supportive for tumor growth
-
Micalizzi, D. S., Wang, C.-A., Farabaugh, S. M., Schiemann, W. P. and Ford, H. L. (2010) Homeoprotein Six1 increases TGF-β Type I receptor and converts TGF-β signaling from suppressive to supportive for tumor growth. Cancer Res. 70, 10371-10380.
-
(2010)
Cancer Res
, vol.70
, pp. 10371-10380
-
-
Micalizzi, D.S.1
Wang, C.-A.2
Farabaugh, S.M.3
Schiemann, W.P.4
Ford, H.L.5
-
51
-
-
26444585020
-
Transforming growth factor-β signaling in stem cells and cancer
-
Mishra, L., Derynck, R. and Mishra, B. (2005) Transforming growth factor-β signaling in stem cells and cancer. Science 310, 68-71.
-
(2005)
Science
, vol.310
, pp. 68-71
-
-
Mishra, L.1
Derynck, R.2
Mishra, B.3
-
52
-
-
78651399324
-
TGF-β-RI kinase inhibitor SD-208 reduces the development and progression of melanoma bone metastases
-
Mohammad, K. S., Javelaud, D., Fournier, P. G., Niewolna, M., McK-enna, C. R., Peng, X. H., Duong, V., Dunn, L. K., Mauviel, A. and Guise, T. A. (2011) TGF-β-RI kinase inhibitor SD-208 reduces the development and progression of melanoma bone metastases. Cancer Res. 71, 175-184.
-
(2011)
Cancer Res
, vol.71
, pp. 175-184
-
-
Mohammad, K.S.1
Javelaud, D.2
Fournier, P.G.3
Niewolna, M.4
McK-enna, C.R.5
Peng, X.H.6
Duong, V.7
Dunn, L.K.8
Mauviel, A.9
Guise, T.A.10
-
53
-
-
33748939751
-
IN-1130, a novel transforming growth factor-β type I receptor kinase (ALK5) inhibitor, suppresses renal fibrosis in obstructive nephropathy
-
Moon, J., Kim, H., Cho, I., Sheen, Y. and Kim, D. (2006) IN-1130, a novel transforming growth factor-β type I receptor kinase (ALK5) inhibitor, suppresses renal fibrosis in obstructive nephropathy. Kidney Int. 70, 1234-1243.
-
(2006)
Kidney Int
, vol.70
, pp. 1234-1243
-
-
Moon, J.1
Kim, H.2
Cho, I.3
Sheen, Y.4
Kim, D.5
-
54
-
-
12144258900
-
Dual role of transforming growth factor β in mammary tumorigenesis and metastatic progression
-
Muraoka-Cook, R. S., Dumont, N. and Arteaga, C. L. (2005) Dual role of transforming growth factor β in mammary tumorigenesis and metastatic progression. Clin. Cancer Res. 11, 937s-943s.
-
(2005)
Clin. Cancer Res
, vol.11
-
-
Muraoka-Cook, R.S.1
Dumont, N.2
Arteaga, C.L.3
-
55
-
-
0036086409
-
Blockade of TGF-β inhibits mammary tumor cell viability, migration, and metastases
-
Muraoka, R. S., Dumont, N., Ritter, C. A., Dugger, T. C., Brantley, D. M., Chen, J., Easterly, E., Roebuck, L. R., Ryan, S. and Gotwals, P. J. (2002) Blockade of TGF-β inhibits mammary tumor cell viability, migration, and metastases. J. Clin. Invest. 109, 1551-1559.
-
(2002)
J. Clin. Invest
, vol.109
, pp. 1551-1559
-
-
Muraoka, R.S.1
Dumont, N.2
Ritter, C.A.3
Dugger, T.C.4
Brantley, D.M.5
Chen, J.6
Easterly, E.7
Roebuck, L.R.8
Ryan, S.9
Gotwals, P.J.10
-
56
-
-
45549085803
-
An anti-transforming growth factor β antibody suppresses metastasis via cooperative effects on multiple cell compartments
-
Nam, J.-S., Terabe, M., Mamura, M., Kang, M.-J., Chae, H., Stuelten, C., Kohn, E., Tang, B., Sabzevari, H. and Anver, M. R. (2008) An anti-transforming growth factor β antibody suppresses metastasis via cooperative effects on multiple cell compartments. Cancer Res. 68, 3835-3843.
-
(2008)
Cancer Res
, vol.68
, pp. 3835-3843
-
-
Nam, J.-S.1
Terabe, M.2
Mamura, M.3
Kang, M.-J.4
Chae, H.5
Stuelten, C.6
Kohn, E.7
Tang, B.8
Sabzevari, H.9
Anver, M.R.10
-
57
-
-
58149236744
-
Roles of TGFβ in metastasis
-
Padua, D. and Massagué, J. (2009) Roles of TGFβ in metastasis. Cell Res. 19, 89-102.
-
(2009)
Cell Res
, vol.19
, pp. 89-102
-
-
Padua, D.1
Massagué, J.2
-
58
-
-
41149157649
-
TGFβ primes breast tumors for lung metastasis seeding through angiopoietin-like 4
-
Padua, D., Zhang, X. H.-F., Wang, Q., Nadal, C., Gerald, W. L., Gomis, R. R. and Massague, J. (2008) TGFβ primes breast tumors for lung metastasis seeding through angiopoietin-like 4. Cell 133, 66-77.
-
(2008)
Cell
, vol.133
, pp. 66-77
-
-
Padua, D.1
Zhang, X.H.-F.2
Wang, Q.3
Nadal, C.4
Gerald, W.L.5
Gomis, R.R.6
Massague, J.7
-
59
-
-
80755163620
-
EW-7195, a novel inhibitor of ALK5 kinase inhibits EMT and breast cancer metastasis to lung
-
Park, C.-Y., Son, J.-Y., Jin, C. H., Nam, J.-S., Kim, D.-K. and Sheen, Y. Y. (2011a) EW-7195, a novel inhibitor of ALK5 kinase inhibits EMT and breast cancer metastasis to lung. Eur. J. Cancer 47, 2642-2653.
-
(2011)
Eur. J. Cancer
, vol.47
, pp. 2642-2653
-
-
Park, C.-Y.1
Son, J.-Y.2
Jin, C.H.3
Nam, J.-S.4
Kim, D.-K.5
Sheen, Y.Y.6
-
60
-
-
84863011208
-
EW-7203, a novel small molecule inhibitor of transforming growth factor-β (TGF-β) type I receptor/activin receptor/like kinase-5, blocks TGF-β1-mediated epithelial-to-mesenchymal transition in mammary epithelial cells
-
Park, C. Y., Kim, D. K. and Sheen, Y. Y. (2011b) EW-7203, a novel small molecule inhibitor of transforming growth factor-β (TGF-β) type I receptor/activin receptor/like kinase-5, blocks TGF-β1-mediated epithelial-to-mesenchymal transition in mammary epithelial cells. Cancer Sci. 102, 1889-1896.
-
(2011)
Cancer Sci
, vol.102
, pp. 1889-1896
-
-
Park, C.Y.1
Kim, D.K.2
Sheen, Y.Y.3
-
61
-
-
0028785603
-
Microsatellite instability and mutations of the transforming growth factor β type II receptor gene in colorectal cancer
-
Parsons, R., Myeroff, L. L., Liu, B., Willson, J. K., Markowitz, S. D., Kinzler, K. W. and Vogelstein, B. (1995) Microsatellite instability and mutations of the transforming growth factor β type II receptor gene in colorectal cancer. Cancer Res. 55, 5548-5550.
-
(1995)
Cancer Res
, vol.55
, pp. 5548-5550
-
-
Parsons, R.1
Myeroff, L.L.2
Liu, B.3
Willson, J.K.4
Markowitz, S.D.5
Kinzler, K.W.6
Vogelstein, B.7
-
62
-
-
27144471111
-
Angiotensin-converting enzyme inhibitors a new mechanism of action
-
Peng, H., Carretero, O. A., Vuljaj, N., Liao, T.-D., Motivala, A., Peterson, E. L. and Rhaleb, N.-E. (2005) Angiotensin-converting enzyme inhibitors a new mechanism of action. Circulation 112, 2436-2445.
-
(2005)
Circulation
, vol.112
, pp. 2436-2445
-
-
Peng, H.1
Carretero, O.A.2
Vuljaj, N.3
Liao, T.-D.4
Motivala, A.5
Peterson, E.L.6
Rhaleb, N.-E.7
-
63
-
-
73349100507
-
Global trends in breast cancer incidence and mortality
-
Porter, P. L. (2009) Global trends in breast cancer incidence and mortality. Salud Publica Mex. 51, s141-s146.
-
(2009)
Salud Publica Mex
, vol.51
-
-
Porter, P.L.1
-
64
-
-
0042307513
-
The two faces of transforming growth factor β in carcinogenesis
-
Roberts, A. B. and Wakefield, L. M. (2003) The two faces of transforming growth factor β in carcinogenesis. Proc. Natl. Acad. Sci. U.S.A. 100, 8621-8623.
-
(2003)
Proc. Natl. Acad. Sci. U.S.A
, vol.100
, pp. 8621-8623
-
-
Roberts, A.B.1
Wakefield, L.M.2
-
65
-
-
0036050857
-
Soluble type II transforming growth factor-β receptor attenuates expression of metastasis-associated genes and suppresses pancreatic cancer cell metastasis1
-
Rowland-Goldsmith, M. A., Maruyama, H., Matsuda, K., Idezawa, T., Ralli, M., Ralli, S. and Korc, M. (2002) Soluble type II transforming growth factor-β receptor attenuates expression of metastasis-associated genes and suppresses pancreatic cancer cell metastasis1. Mol. Cancer Ther. 1, 161-167.
-
(2002)
Mol. Cancer Ther
, vol.1
, pp. 161-167
-
-
Rowland-Goldsmith, M.A.1
Maruyama, H.2
Matsuda, K.3
Idezawa, T.4
Ralli, M.5
Ralli, S.6
Korc, M.7
-
66
-
-
0035914297
-
Synergistic cooperation between hypoxia and transforming growth factor-β pathways on human vascular endothelial growth factor gene expression
-
Sánchez-Elsner, T., Botella, L. M., Velasco, B., Corbí, A., Attisano, L. and Bernabéu, C. (2001) Synergistic cooperation between hypoxia and transforming growth factor-β pathways on human vascular endothelial growth factor gene expression. J. Biol. Chem. 276, 38527-38535.
-
(2001)
J. Biol. Chem
, vol.276
, pp. 38527-38535
-
-
Sánchez-Elsner, T.1
Botella, L.M.2
Velasco, B.3
Corbí, A.4
Attisano, L.5
Bernabéu, C.6
-
67
-
-
79955762358
-
Healthy lifestyle on the risk of breast cancer
-
Sánchez-Zamorano, L. M., Flores-Luna, L., Ángeles-Llerenas, A., Romieu, I., Lazcano-Ponce, E., Miranda-Hernández, H., Mainero-Ratchelous, F. and Torres-Mejía, G. (2011) Healthy lifestyle on the risk of breast cancer. Cancer Epidemiol. Biomarkers Prev. 20, 912-922.
-
(2011)
Cancer Epidemiol. Biomarkers Prev
, vol.20
, pp. 912-922
-
-
Sánchez-Zamorano, L.M.1
Flores-Luna, L.2
Ángeles-Llerenas, A.3
Romieu, I.4
Lazcano-Ponce, E.5
Miranda-Hernández, H.6
Mainero-Ratchelous, F.7
Torres-Mejía, G.8
-
68
-
-
4444220447
-
Novel oncogenic protein kinase inhibitors for cancer therapy
-
Sawyer, T. K. (2004) Novel oncogenic protein kinase inhibitors for cancer therapy. Curr. Med. Chem. Anticancer Agents 4, 449-455.
-
(2004)
Curr. Med. Chem. Anticancer Agents
, vol.4
, pp. 449-455
-
-
Sawyer, T.K.1
-
69
-
-
79956217912
-
Transforming growth factor-beta 2 gene silencing with trabedersen (AP 12009) in pancreatic cancer
-
Schlingensiepen, K. H., Jaschinski, F., Lang, S. A., Moser, C., Geissler, E. K., Schlitt, H. J., Kielmanowicz, M. and Schneider, A. (2011) Transforming growth factor-beta 2 gene silencing with trabedersen (AP 12009) in pancreatic cancer. Cancer Sci. 102, 1193-1200.
-
(2011)
Cancer Sci
, vol.102
, pp. 1193-1200
-
-
Schlingensiepen, K.H.1
Jaschinski, F.2
Lang, S.A.3
Moser, C.4
Geissler, E.K.5
Schlitt, H.J.6
Kielmanowicz, M.7
Schneider, A.8
-
70
-
-
0038682002
-
Mechanisms of TGF-β signaling from cell membrane to the nucleus
-
Shi, Y. and Massagué, J. (2003) Mechanisms of TGF-β signaling from cell membrane to the nucleus. Cell 113, 685-700.
-
(2003)
Cell
, vol.113
, pp. 685-700
-
-
Shi, Y.1
Massagué, J.2
-
71
-
-
77649274997
-
Inhibitory effect of a TGFβ receptor type-I inhibitor, Ki26894, on invasiveness of scirrhous gastric cancer cells
-
Shinto, O., Yashiro, M., Kawajiri, H., Shimizu, K., Shimizu, T., Miwa, A. and Hirakawa, K. (2010) Inhibitory effect of a TGFβ receptor type-I inhibitor, Ki26894, on invasiveness of scirrhous gastric cancer cells. Br. J. Cancer 102, 844-851.
-
(2010)
Br. J. Cancer
, vol.102
, pp. 844-851
-
-
Shinto, O.1
Yashiro, M.2
Kawajiri, H.3
Shimizu, K.4
Shimizu, T.5
Miwa, A.6
Hirakawa, K.7
-
72
-
-
79951813692
-
TGF-β regulates isoform switching of FGF receptors and epithelial-mesenchymal transition
-
Shirakihara, T., Horiguchi, K., Miyazawa, K., Ehata, S., Shibata, T., Morita, I., Miyazono, K. and Saitoh, M. (2011) TGF-β regulates isoform switching of FGF receptors and epithelial-mesenchymal transition. EMBO J. 30, 783-795.
-
(2011)
EMBO J
, vol.30
, pp. 783-795
-
-
Shirakihara, T.1
Horiguchi, K.2
Miyazawa, K.3
Ehata, S.4
Shibata, T.5
Morita, I.6
Miyazono, K.7
Saitoh, M.8
-
73
-
-
3442894138
-
Targeting endogenous transforming growth factor β receptor signaling in SMAD4-deficient human pancreatic carcinoma cells inhibits their invasive phenotype 1
-
Subramanian, G., Schwarz, R. E., Higgins, L., McEnroe, G., Chakra-varty, S., Dugar, S. and Reiss, M. (2004) Targeting endogenous transforming growth factor β receptor signaling in SMAD4-deficient human pancreatic carcinoma cells inhibits their invasive phenotype 1. Cancer Res. 64, 5200-5211.
-
(2004)
Cancer Res
, vol.64
, pp. 5200-5211
-
-
Subramanian, G.1
Schwarz, R.E.2
Higgins, L.3
McEnroe, G.4
Chakra-Varty, S.5
Dugar, S.6
Reiss, M.7
-
74
-
-
0030897038
-
Mutation analysis of coding sequences of the entire transforming growth factor beta type II receptor gene in sporadic human colon cancer using genomic DNA and intron primers
-
Takenoshita, S., Tani, M., Nagashima, M., Hagiwara, K., Bennett, W. P., Yokota, J. and Harris, C. C. (1997) Mutation analysis of coding sequences of the entire transforming growth factor beta type II receptor gene in sporadic human colon cancer using genomic DNA and intron primers. Oncogene 14, 1255-1258.
-
(1997)
Oncogene
, vol.14
, pp. 1255-1258
-
-
Takenoshita, S.1
Tani, M.2
Nagashima, M.3
Hagiwara, K.4
Bennett, W.P.5
Yokota, J.6
Harris, C.C.7
-
75
-
-
78650305162
-
TGF-β inhibition restores terminal osteoblast differentiation to suppress myeloma growth
-
Takeuchi, K., Abe, M., Hiasa, M., Oda, A., Amou, H., Kido, S., Harada, T., Tanaka, O., Miki, H. and Nakamura, S. (2010) TGF-β inhibition restores terminal osteoblast differentiation to suppress myeloma growth. PLoS One 5, e9870.
-
(2010)
PLoS One
, vol.e9870
, pp. 5
-
-
Takeuchi, K.1
Abe, M.2
Hiasa, M.3
Oda, A.4
Amou, H.5
Kido, S.6
Harada, T.7
Tanaka, O.8
Miki, H.9
Nakamura, S.10
-
76
-
-
78649402748
-
Transforming growth factor β signaling inhibitor, SB-431542, induces maturation of dendritic cells and enhances anti-tumor activity
-
Tanaka, H., Shinto, O., Yashiro, M., Yamazoe, S., Iwauchi, T., Muguru-ma, K., Kubo, N., Ohira, M. and Hirakawa, K. (2010) Transforming growth factor β signaling inhibitor, SB-431542, induces maturation of dendritic cells and enhances anti-tumor activity. Oncol. Rep. 24, 1637-1643.
-
(2010)
Oncol. Rep
, vol.24
, pp. 1637-1643
-
-
Tanaka, H.1
Shinto, O.2
Yashiro, M.3
Yamazoe, S.4
Iwauchi, T.5
Muguru-Ma, K.6
Kubo, N.7
Ohira, M.8
Hirakawa, K.9
-
77
-
-
70450198396
-
Epi-thelial-mesenchymal transitions in development and disease
-
Thiery, J. P., Acloque, H., Huang, R. Y. and Nieto, M. A. (2009) Epi-thelial-mesenchymal transitions in development and disease. Cell 139, 871-890.
-
(2009)
Cell
, vol.139
, pp. 871-890
-
-
Thiery, J.P.1
Acloque, H.2
Huang, R.Y.3
Nieto, M.A.4
-
78
-
-
27644457376
-
TGF-β directly targets cyto-toxic T cell functions during tumor evasion of immune surveillance
-
Thomas, D. A. and Massagué, J. (2005) TGF-β directly targets cyto-toxic T cell functions during tumor evasion of immune surveillance. Cancer Cell 8, 369-380.
-
(2005)
Cancer Cell
, vol.8
, pp. 369-380
-
-
Thomas, D.A.1
Massagué, J.2
-
79
-
-
33746034613
-
Transforming growth factor-β employs HMGA2 to elicit epithelial-mesenchymal transition
-
Thuault, S., Valcourt, U., Petersen, M., Manfi oletti, G., Heldin, C.-H. and Moustakas, A. (2006) Transforming growth factor-β employs HMGA2 to elicit epithelial-mesenchymal transition. J. Cell Biol. 174, 175-183.
-
(2006)
J. Cell Biol
, vol.174
, pp. 175-183
-
-
Thuault, S.1
Valcourt, U.2
Petersen, M.3
Manfioletti, G.4
Heldin, C.-H.5
Moustakas, A.6
-
80
-
-
77953688386
-
Gene-environment interactions in 7610 women with breast cancer: Prospective evidence from the Million Women Study
-
Travis, R. C., Reeves, G. K., Green, J., Bull, D., Tipper, S. J., Baker, K., Beral, V., Peto, R., Bell, J. and Zelenika, D. (2010) Gene-environment interactions in 7610 women with breast cancer: prospective evidence from the Million Women Study. Lancet 375, 2143-2151.
-
(2010)
Lancet
, vol.375
, pp. 2143-2151
-
-
Travis, R.C.1
Reeves, G.K.2
Green, J.3
Bull, D.4
Tipper, S.J.5
Baker, K.6
Beral, V.7
Peto, R.8
Bell, J.9
Zelenika, D.10
-
81
-
-
7444226411
-
SD-208, a novel transforming growth factor β receptor I kinase inhibitor, inhibits growth and invasiveness and enhances immunogenicity of murine and human glioma cells in vitro and in vivo
-
Uhl, M., Aulwurm, S., Wischhusen, J., Weiler, M., Ma, J. Y., Almirez, R., Mangadu, R., Liu, Y.-W., Platten, M. and Herrlinger, U. (2004) SD-208, a novel transforming growth factor β receptor I kinase inhibitor, inhibits growth and invasiveness and enhances immunogenicity of murine and human glioma cells in vitro and in vivo. Cancer Res. 64, 7954-7961.
-
(2004)
Cancer Res
, vol.64
, pp. 7954-7961
-
-
Uhl, M.1
Aulwurm, S.2
Wischhusen, J.3
Weiler, M.4
Ma, J.Y.5
Almirez, R.6
Mangadu, R.7
Liu, Y.-W.8
Platten, M.9
Herrlinger, U.10
-
82
-
-
84861557944
-
Anti-human activin receptor-like kinase 1 (ALK1) antibody attenuates bone morphogenetic protein 9 (BMP9)-induced ALK1 signaling and interferes with endothelial cell sprouting
-
van Meeteren, L. A., Thorikay, M., Bergqvist, S., Pardali, E., Stampino, C. G., Hu-Lowe, D., Goumans, M.-J. and Ten Dijke, P. (2012) Anti-human activin receptor-like kinase 1 (ALK1) antibody attenuates bone morphogenetic protein 9 (BMP9)-induced ALK1 signaling and interferes with endothelial cell sprouting. J. Biol. Chem. 287, 18551-18561.
-
(2012)
J. Biol. Chem
, vol.287
, pp. 18551-18561
-
-
van Meeteren, L.A.1
Thorikay, M.2
Bergqvist, S.3
Pardali, E.4
Stampino, C.G.5
Hu-Lowe, D.6
Goumans, M.-J.7
Ten Dijke, P.8
-
83
-
-
69549128378
-
A role for the TGFβ-Par6 polarity pathway in breast cancer progression
-
Viloria-Petit, A. M., David, L., Jia, J. Y., Erdemir, T., Bane, A. L., Pinn-aduwage, D., Roncari, L., Narimatsu, M., Bose, R. and Moffat, J. (2009) A role for the TGFβ-Par6 polarity pathway in breast cancer progression. Proc. Natl. Acad. Sci. U.S.A. 106, 14028-14033.
-
(2009)
Proc. Natl. Acad. Sci. U.S.A
, vol.106
, pp. 14028-14033
-
-
Viloria-Petit, A.M.1
David, L.2
Jia, J.Y.3
Erdemir, T.4
Bane, A.L.5
Pinn-Aduwage, D.6
Roncari, L.7
Narimatsu, M.8
Bose, R.9
Moffat, J.10
-
84
-
-
0036467496
-
TGF-β signaling: Positive and negative effects on tumorigenesis
-
Wakefi eld, L. M. and Roberts, A. B. (2002) TGF-β signaling: positive and negative effects on tumorigenesis. Curr. Opin. Genet. Dev. 12, 22-29.
-
(2002)
Curr. Opin. Genet. Dev
, vol.12
, pp. 22-29
-
-
Wakefield, L.M.1
Roberts, A.B.2
-
85
-
-
0034662637
-
Analysis of specific gene mutations in the transforming growth factor-β signal transduction pathway in human ovarian cancer
-
Wang, D., Kanuma, T., Mizunuma, H., Takama, F., Ibuki, Y., Wake, N., Mogi, A., Shitara, Y. and Takenoshita, S. (2000) Analysis of specific gene mutations in the transforming growth factor-β signal transduction pathway in human ovarian cancer. Cancer Res. 60, 4507-4512.
-
(2000)
Cancer Res
, vol.60
, pp. 4507-4512
-
-
Wang, D.1
Kanuma, T.2
Mizunuma, H.3
Takama, F.4
Ibuki, Y.5
Wake, N.6
Mogi, A.7
Shitara, Y.8
Takenoshita, S.9
-
86
-
-
78649987710
-
Transforming growth factor-β-induced epithelial-mesenchymal transition facilitates epidermal growth factor-dependent breast cancer progression
-
Wendt, M. K., Smith, J. A. and Schiemann, W. P. (2010) Transforming growth factor-β-induced epithelial-mesenchymal transition facilitates epidermal growth factor-dependent breast cancer progression. Oncogene 29, 6485-6498.
-
(2010)
Oncogene
, vol.29
, pp. 6485-6498
-
-
Wendt, M.K.1
Smith, J.A.2
Schiemann, W.P.3
-
87
-
-
79960838436
-
The TGF-β/Smad pathway induces breast cancer cell invasion through the up-regulation of matrix metalloproteinase 2 and 9 in a spheroid invasion model system
-
Wiercinska, E., Naber, H. P., Pardali, E., van der Pluijm, G., van Dam, H. and Ten Dijke, P. (2011) The TGF-β/Smad pathway induces breast cancer cell invasion through the up-regulation of matrix metalloproteinase 2 and 9 in a spheroid invasion model system. Breast Cancer Res. Treat. 128, 657-666.
-
(2011)
Breast Cancer Res. Treat
, vol.128
, pp. 657-666
-
-
Wiercinska, E.1
Naber, H.P.2
Pardali, E.3
van der Pluijm, G.4
van Dam, H.5
Ten Dijke, P.6
-
88
-
-
0033606964
-
Smad2 and Smad4 gene mutations in hepatocellular carcinoma
-
Yakicier, M., Irmak, M., Romano, A., Kew, M. and Ozturk, M. (1999) Smad2 and Smad4 gene mutations in hepatocellular carcinoma. Oncogene 18, 4879-4883.
-
(1999)
Oncogene
, vol.18
, pp. 4879-4883
-
-
Yakicier, M.1
Irmak, M.2
Romano, A.3
Kew, M.4
Ozturk, M.5
-
89
-
-
0036087521
-
Lifetime exposure to a soluble TGF-β antagonist protects mice against metastasis without adverse side effects
-
Yang, Y.-A., Dukhanina, O., Tang, B., Mamura, M., Letterio, J. J., Mac-Gregor, J., Patel, S. C., Khozin, S., Liu, Z.-y. and Green, J. (2002) Lifetime exposure to a soluble TGF-β antagonist protects mice against metastasis without adverse side effects. J. Clin. Invest. 109, 1607-1615.
-
(2002)
J. Clin. Invest
, vol.109
, pp. 1607-1615
-
-
Yang, Y.-A.1
Dukhanina, O.2
Tang, B.3
Mamura, M.4
Letterio, J.J.5
Mac-Gregor, J.6
Patel, S.C.7
Khozin, S.8
Liu, Z.-Y.9
Green, J.10
-
90
-
-
10444261212
-
Development of TGF-β signalling inhibitors for cancer therapy
-
Yingling, J. M., Blanchard, K. L. and Sawyer, J. S. (2004) Development of TGF-β signalling inhibitors for cancer therapy. Nat. Rev. Drug Discov. 3, 1011-1022.
-
(2004)
Nat. Rev. Drug Discov
, vol.3
, pp. 1011-1022
-
-
Yingling, J.M.1
Blanchard, K.L.2
Sawyer, J.S.3
-
91
-
-
61849183646
-
Targeting transforming growth factor-β signaling in liver metastasis of colon cancer
-
Zhang, B., Halder, S. K., Zhang, S. and Datta, P. K. (2009) Targeting transforming growth factor-β signaling in liver metastasis of colon cancer. Cancer Lett. 277, 114-120.
-
(2009)
Cancer Lett
, vol.277
, pp. 114-120
-
-
Zhang, B.1
Halder, S.K.2
Zhang, S.3
Datta, P.K.4
-
92
-
-
0033168915
-
Regulation of Smad signalling by protein associations and signalling crosstalk
-
Zhang, Y. and Derynck, R. (1999) Regulation of Smad signalling by protein associations and signalling crosstalk. Trends Cell Biol. 9, 274-279.
-
(1999)
Trends Cell Biol
, vol.9
, pp. 274-279
-
-
Zhang, Y.1
Derynck, R.2
|